Acinic cell carcinoma natural history, complications and prognosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 2: | Line 2: | ||
{{Swathi}} | {{Swathi}} | ||
*Acinic cell carcinoma is a slow growing tumor | *Acinic cell carcinoma is a slow growing tumor <ref name="Al-ZaherObeid2009">{{cite journal|last1=Al-Zaher|first1=Nabil|last2=Obeid|first2=Amani|last3=Al-Salam|first3=Suhail|last4=Al-Kayyali|first4=Bassam Sulaiman|title=Acinic cell carcinoma of the salivary glands: A literature review|journal=Hematology/Oncology and Stem Cell Therapy|volume=2|issue=1|year=2009|pages=259–264|issn=16583876|doi=10.1016/S1658-3876(09)50035-0}}</ref> | ||
*Tumor may affect the facial nerve or other adjacent tissues depending on its location | *Tumor may affect the facial nerve or other adjacent tissues depending on its location | ||
*Prognosis is most favorable when the parotid gland is involved | *Prognosis is most favorable when the parotid gland is involved | ||
Revision as of 13:16, 9 August 2019
Natural History, Complications & Prognosis
Swathi Venkatesan, M.B.B.S.[1]
- Acinic cell carcinoma is a slow growing tumor [1]
- Tumor may affect the facial nerve or other adjacent tissues depending on its location
- Prognosis is most favorable when the parotid gland is involved
- Progression of acinic cell carcinoma is slow but it may involve adjacent tissues if not treated adequately.
- Acinic cell carcinoma can spread to adjacent organs and eventually be lethal if not intervened on time.
- The prognosis is more favorable when the tumor is in a major salivary gland; the parotid gland is most favorable, followed by the submandibular gland
- The least favorable primary sites are the sublingual and minor salivary glands
- Large bulky tumors or high-grade tumors carry a least favorable or poor prognosis and may best be treated by surgical resection combined with postoperative radiation therapy
- ↑ Al-Zaher, Nabil; Obeid, Amani; Al-Salam, Suhail; Al-Kayyali, Bassam Sulaiman (2009). "Acinic cell carcinoma of the salivary glands: A literature review". Hematology/Oncology and Stem Cell Therapy. 2 (1): 259–264. doi:10.1016/S1658-3876(09)50035-0. ISSN 1658-3876.